Advertisement
Noticias de Forex
JetBlue, Allegiant Ink Divestiture Deal In Connection With JetBlue's Combination With Spirit
JetBlue Airways Corp. (JBLU) and Allegiant (ALGT) announced Monday that the airlines have entered into a definitive agreement under which JetBlue will transfer to Allegiant all of the holdings of Spirit Airlines, Inc. (SAVE) at Boston Logan International Airport and Newark Liberty International Airport.
RTTNews |
hace 700
U.S. Dollar Lower Ahead Of Inflation Data
The U.S. dollar fell against its most major rivals in the European session on Monday, as investors await U.S. inflation data that could influence the Federal Reserve's interest rate path for the rest of the year.
RTTNews
|
hace 700
Neumora Therapeutics Announces IPO Of 14.71 Mln Shares To Be Priced Between $16.00 And $18.00/Share
Biopharmaceutical company Neumora Therapeutics, Inc. revealed Monday that it will offer 14.71 million shares of its common stock in an initial public offering and expects the IPO price to be between $16.00 and $18.00 per share, according to an amended Form S-1 filing with the U.S. Securities and Exchange Commission.
RTTNews
|
hace 700
RayzeBio Announces IPO Of 14.40 Mln Shares To Be Priced Between $16.00 And $18.00/Share
Radiopharmaceutical therapeutics company RayzeBio, Inc. revealed Monday that it will offer 14.40 million shares of its common stock in an initial public offering and expects the IPO price to be between $16.00 and $18.00 per share, according to an amended Form S-1 filing with the U.S. Securities and Exchange Commission.
RTTNews
|
hace 700
Eurozone To Undergo Slower Growth On Subdued Domestic Demand, Tight Policy
The euro area economy is set to log a weaker-than-estimated growth this year and next as rising consumer prices continue to weigh on domestic demand and monetary policy tightening works its way through the economy. In the summer interim forecast, released Monday, the European Commission said the 20-nation currency bloc will grow 0.8 percent in 2023, which was revised down from 1.1 percent projec
RTTNews
|
hace 700
Bird Global Appoints Joseph Prodan To Succeed Michael Washinushi As CFO
Electric transportation company Bird Global, Inc. (BRDS) announced Monday the appointment of Joseph (Joe) Prodan as Chief Financial Officer (CFO), effective August 30, 2023. Prodan succeeds Michael Washinushi, following his recent appointment to Interim CEO.
RTTNews
|
hace 700
Kellogg Board Approves Separation Into Two Independent, Publicly Traded Companies
Kellogg Co. (K) announced Monday that its Board of Directors formally approved the previously announced separation into two independent, publicly traded companies, Kellanova and WK Kellogg Co.
RTTNews
|
hace 700
more news
InflaRx Reports Positive Topline Results From SAD Phase I Study With C5aR Inhibitor INF904
Biotechnology company InflaRx N.V. (IFRX) announced Monday topline results from the single ascending dose (SAD) part of its randomized, double-blind, placebo-controlled Phase I trial of the orally administered, low molecular weight C5aR inhibitor INF904.
RTTNews
|
hace 700
Bay Street Likely To Open Higher
Canadian shares are likely to open on a positive note on Monday, tracking European markets and higher bullion prices.
RTTNews
|
hace 700
Welltower Boosts FY23 NFFO Guidance
Healthcare infrastructure company Welltower Inc. (WELL) on Monday raised its earnings guidance for the full-year 2023.
RTTNews
|
hace 700
Moderna, Immatics Ink Strategic Multi-Platform Collaboration To Develop Oncology Therapeutics
Biopharmaceutical company Moderna, Inc. (MRNA) and Germany-based Immatics N.V. (IMTX) announced Monday a strategic research and development collaboration to pioneer novel and transformative therapies for cancer patients with high unmet medical need.
RTTNews
|
hace 700
Takeda Reports Positive Topline Results Of Phase 2b Study Of TAK-279 For Active Psoriatic Arthritis
Takeda Pharmaceutical Co. Ltd. (TAK, TKPHF.PK) announced Monday positive topline results from its randomized, double-blind, placebo-controlled, multiple-dose Phase 2b trial evaluating TAK-279, an investigational oral allosteric tyrosine kinase 2 (TYK2) inhibitor with next generation selectivity, in people with active psoriatic arthritis.
RTTNews
|
hace 700
Sensex, Nifty Extend Winning Streak As Adani And PSU Stocks Climb
Indian shares extended their winning streak for the seventh day running on Monday, as enthusiasm over the G20 Summit outweighed muted cues from global markets.
RTTNews
|
hace 700
Stay up to date!
Add Noticias to your browser
Add To Chrome
